EIF2A and amyotrophic lateral sclerosis: This revealed a significant 1.79-fold increase in the ratio of phospho-EIF2α/EIF2α protein levels compared to controls (Fig. 4b–d), a result previously reported for C9 ALS/FTD brain samples34.